Definium Reports Third Phase 3 Win for Fast-Dissolve LSD Therapy

Definium’s DT120 ODT LSD tablet cut GAD anxiety scores 5.1 points vs placebo in Phase 3. Effects started by day 2. FDA filing targeted for 2027.